DeepMed Research

COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Optimal Timing of Exercise Initiation Within a Lifestyle Weight Loss Program

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Standard BT
Behavioral: Sequential BT

First Posted Date: 2013-11-15

Last Posted Date: 2023-09-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 170

Registration Number: NCT01985568

Locations: 🇺🇸
University of Colorado, Anschutz Health and Wellness Center, Aurora, Colorado, United States

Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry

Not Applicable

Terminated

Conditions: Pain

Interventions: Drug: oral placebo
Drug: Oral Analgesics

First Posted Date: 2013-10-29

Last Posted Date: 2021-01-22

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 88

Registration Number: NCT01971853

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study

Phase 2

Completed

Conditions: Uterine Hemorrhage
Contraception

Interventions: Drug: Placebo Sugar Pill
Drug: Combined Oral Contraceptive Pill

First Posted Date: 2013-10-23

Last Posted Date: 2016-05-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 32

Registration Number: NCT01968135

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes
Cardiovascular Disease

Interventions: Drug: Sitagliptin
Drug: Glimepiride
Drug: Placebo

First Posted Date: 2013-09-26

Last Posted Date: 2023-07-12

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 36

Registration Number: NCT01951339

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

DS-Connect®: The Down Syndrome Registry

Recruiting

Conditions: Down Syndrome

First Posted Date: 2013-09-25

Last Posted Date: 2025-01-31

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 100000

Registration Number: NCT01950624

Locations: 🇺🇸
Linda Crnic Institute for Down Syndrome, Aurora, Colorado, United States

Evaluation of Potential Allergenicity of New Soybean Varieties

Terminated

Conditions: Soy Allergy

Interventions: Other: Oral food challenge

First Posted Date: 2013-09-25

Last Posted Date: 2018-07-13

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 10

Registration Number: NCT01950559

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Comparing Strategies for Translating Self-management Support Into Primary Care

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Behavioral: Connection to Health Interactive Behavior Change Technology
Behavioral: Self-management support education
Behavioral: Connection to Health plus Coaching (CTH+C)

First Posted Date: 2013-09-19

Last Posted Date: 2017-12-20

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 901

Registration Number: NCT01945918

Locations: 🇺🇸
University of Colorado at Denver and Health Sciences Center, Aurora, Colorado, United States

Functional Prehabilitation and Major Elective Surgery

Not Applicable

Completed

Conditions: Surgical Complication
Timed Up and Go
Physical Therapy

Interventions: Procedure: Functional Assessment
Procedure: Prehabilitation

First Posted Date: 2013-09-17

Last Posted Date: 2015-07-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 16

Registration Number: NCT01943773

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸
Denver Veterans Affairs Medical Center, Denver, Colorado, United States

A New Approach to Measuring Energy Expenditure in Humans

Completed

Conditions: Human Energy Expenditure

First Posted Date: 2013-09-10

Last Posted Date: 2019-10-09

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 72

Registration Number: NCT01938794

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers

Phase 2

Completed

Conditions: Recurrent Non-small Cell Lung Cancer
Recurrent Small Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Adenocarcinoma of the Lung
Stage IV Non-small Cell Lung Cancer
Extensive Stage Small Cell Lung Cancer
Limited Stage Small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer

Interventions: Drug: Ponatinib

First Posted Date: 2013-09-05

Last Posted Date: 2022-02-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 171

Registration Number: NCT01935336

Locations: 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy